Vaccinex, Inc.
VCNX- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001205922
No open-market purchases or sales by Vaccinex, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Vaccinex, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- +4 vs. Q4 2021
- Shares held
- 4.25M
- +2.65M (+166.1%) vs. Q4 2021
- Total value
- $5.49M
- +$3.83M (+230.6%) vs. Q4 2021
- New holders
- 8
- 7 more added
- Sold out
- 4
- 4 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VCNX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 1 | $45 |
| Q3 2024 | 12 | $1.14M |
| Q2 2024 | 11 | $1.81M |
| Q1 2024 | 12 | $2.39M |
| Q4 2023 | 18 | $1.07M |
| Q3 2023 | 19 | $2.92M |
| Q2 2023 | 23 | $994.8K |
| Q1 2023 | 24 | $1.10M |
| Q4 2022 | 25 | $3.12M |
| Q3 2022 | 22 | $2.28M |
| Q2 2022 | 27 | $5.03M |
| Q1 2022 | 25 | $5.49M |
| Q4 2021 | 21 | $1.66M |
| Q3 2021 | 23 | $3.36M |
| Q2 2021 | 28 | $4.54M |
| Q1 2021 | 33 | $2.79M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Vaccinex, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| AIGH Capital Management LLC | 2,081,801 | $2.63M | 0.95% | +2,081,801 | New |
| Vanguard Group Inc | 727,265 | $960.0K | 0.00% | +104,083+16.7% | Added |
| Telemetry Investments, L.L.C. | 540,000 | $713.0K | 1.14% | +407,000+306.0% | Added |
| Geode Capital Management, LLC | 236,715 | $312.0K | 0.00% | +108,383+84.5% | Added |
| Point72 Asset Management, L.P. | 226,593 | $299.0K | 0.00% | −168,929−42.7% | Reduced |
| Citadel Advisors LLC | 67,768 | $90.0K | 0.00% | −13,656−16.8% | Reduced |
| State Street Corp | 67,800 | $89.0K | 0.00% | 00.0% | Unchanged |
| Worth Venture Partners, LLC | 66,856 | $88.0K | 0.04% | +66,856 | New |
| BlackRock Inc. | 47,520 | $63.0K | 0.00% | −2,196−4.4% | Reduced |
| Susquehanna International Group, LLP | 34,521 | $46.0K | 0.00% | +12,485+56.7% | Added |
| Millennium Management LLC | 30,879 | $41.0K | 0.00% | +30,879 | New |
| Northern Trust Corp | 16,702 | $22.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 16,823 | $22.0K | 0.00% | +16,823 | New |
| HRT Financial LP | 16,534 | $21.0K | 0.00% | +16,534 | New |
| Oppenheimer & Co Inc | 14,351 | $19.0K | 0.00% | 00.0% | Unchanged |
| Creative Planning | 11,000 | $15.0K | 0.00% | 00.0% | Unchanged |
| Vectors Research Management, LLC | 10,000 | $13.0K | 0.00% | +5,000+100.0% | Added |
| Moors & Cabot, Inc. | 10,000 | $13.0K | 0.00% | +10,000 | New |
| HNP Capital LLC | 10,000 | $13.0K | 0.00% | +10,000 | New |
| Royal Bank of Canada | 5,153 | $7.00K | 0.00% | +5,153 | New |
| Group One Trading, L.P. | 4,894 | $6.00K | 0.00% | +3,705+311.6% | Added |
| Advisor Group Holdings, Inc. | 3,500 | $5.00K | 0.00% | −800−18.6% | Reduced |
| Ancora Advisors, LLC | 2,000 | $3.00K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 1,160 | $1.00K | 0.00% | +860+286.7% | Added |
| Wells Fargo & Company | 110 | $0 | 0.00% | 00.0% | Unchanged |
| Natixis | 0 | $0 | 0.00% | −31,895−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −5,655−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −3,273−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −182−100.0% | Sold out |